Harmony Biosciences LLC

Address: 630 West Germantown Pike Suite 215

Sponsor Overview

assignment

Specializations

Prader-Willi syndrome

Clinical research is centered on Prader-Willi syndrome, with attention to the neurological and behavioral burden associated with the condition.

Excessive daytime sleepiness
Sleep-wake disturbance
Neurodevelopmental disorder

The sponsor’s activity in this area reflects a focused interest in symptoms that affect alertness, daily functioning, and quality of life in people living with this rare disorder.

Sleep medicine

Research interest extends to sleep medicine, particularly conditions involving impaired wakefulness and disrupted sleep regulation.

Daytime sleepiness
Wakefulness regulation
Sleep-related symptoms

This area highlights therapeutic attention to symptoms that interfere with sustained attention, activity, and routine functioning.

Neurology and neurobehavioral care

The sponsor’s trial portfolio includes interest in neurological and neurobehavioral manifestations linked to a complex genetic disorder.

Cognitive and behavioral symptoms
Central nervous system regulation
Rare disease neurology

These topics are relevant to symptom domains that shape long-term care needs in rare neurological disorders.

Rare disease therapeutics

Research activity is directed toward rare disease therapeutics, with emphasis on treatment options for a genetically defined pediatric and adult population.

Genetic disorder management
Symptom-focused therapy
Orphan disease treatment

The therapeutic focus is concentrated on addressing a specific unmet need within Prader-Willi syndrome care.

Trial Name	Country	Status
Efficacy and Safety of Pitolisant Hydrochloride in Prader-Willi Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study	Belgium Czechia Denmark France Germany Italy Poland Romania Spain Sweden	Recruiting